Left Renal Vein Ligation in Patients With Liver Cirrhosis and Spontaneous Splenorenal Shunt in Liver Transplantation
Transplantation Proceedings · 2026
DOI: 10.1016/j.transproceed.2026.07.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplantation Proceedings, 2026. Verfasst von Alexandre Corrente de Oliveira und 18 weiteren Autor:innen. Beteiligte Einrichtung: University of Brasília, Brasília, Brazil. Electronic address: Corrente.usmle@gmail.com. Hauptthemen laut MEDLINE: Liver Transplantation, Renal Veins, Liver Cirrhosis. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Adequate hepatopetal portal venous inflow is a prerequisite for graft viability and functional recovery after liver transplantation. In some recipients, large portosystemic collaterals persist despite transplantation, diverting portal flow and predisposing to portal steal and subsequent graft dysfunction. Spontaneous splenorenal shunts (SSS) represent a particularly challenging manifestation of this phenomenon. Several surgical strategies have been proposed to restore effective portal inflow, including splenectomy, shunt ligation, and left renal vein ligation (LRVL). Compared with alternative approaches, LRVL is technically easier and less invasive, making it an attractive adjunctive maneuver. However, its optimal indications and long-term clinical consequences-particularly with respect to graft performance and renal function-remain incompletely defined. Although prior reports suggest that LRVL can attenuate portosystemic shunting and enhance hepatopetal portal flow, the existing evidence is heterogeneous and largely derived from small, single-center series. In this study, we compared outcomes among liver transplant recipients with SSS managed with or without LRVL, with a focus on perioperative outcomes, graft-related complications, renal and liver function, and survival, in order to better delineate the clinical role of LRVL. Donors were not prisoners, coerced, or paid.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- University of Brasília, Brasília, Brazil. Electronic address: Corrente.usmle@gmail.com.
- University of Brasília, Brasília, Brazil.
- Instituto de Cardiologia e Transplantes do Distrito Federal, Brasília, Brazil; Hospital Brasília, Brasília, Brazil.
- University of Brasília, Brasília, Brazil; Instituto de Cardiologia e Transplantes do Distrito Federal, Brasília, Brazil; Hospital Brasília, Brasília, Brazil.
Zitieren
APA
de Oliveira, A. C., Moldão, C. M., Costa, J. P. S., Feijó, M. S., da Silva, W. J. P., Terra, E. L. V., Rodrigues, F. S., Figueira, A. V., Morato, T., Romeres, S., Bitencourt, D. S., Rocha, H., Trevizoli, N., Gustavo Dias, L., de Campos, P. B., Cajá, G., Ullmann, R., Jorge, F., & Watanabe, A. L. C. (2026). Left Renal Vein Ligation in Patients With Liver Cirrhosis and Spontaneous Splenorenal Shunt in Liver Transplantation. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2026.07.001
Vancouver
de Oliveira AC, Moldão CM, Costa JPS, Feijó MS, da Silva WJP, Terra ELV, et al. Left Renal Vein Ligation in Patients With Liver Cirrhosis and Spontaneous Splenorenal Shunt in Liver Transplantation. Transplantation Proceedings. 2026. doi:10.1016/j.transproceed.2026.07.001
BibTeX
@article{deOliveira2026,
author = {de Oliveira, Alexandre Corrente and Moldão, Catarina Marcos and Costa, João Pedro Soares and Feijó, Mateus Silva and da Silva, Wilson Júnior Pereira and Terra, Elizandra Letícia Vieira and Rodrigues, Fernanda de Sousa and Figueira, Ana Virginia and Morato, Tiago and Romeres, Silas and Bitencourt, Danielle Sacchi and Rocha, Henrique and Trevizoli, Natalia and Gustavo Dias, Luiz and de Campos, Priscilla Brizolla and Cajá, Gabriel and Ullmann, Raquel and Jorge, Fernando and Watanabe, Andre Luis Conde},
title = {Left Renal Vein Ligation in Patients With Liver Cirrhosis and Spontaneous Splenorenal Shunt in Liver Transplantation},
journal = {Transplantation Proceedings},
year = {2026},
doi = {10.1016/j.transproceed.2026.07.001}
}
EUVIMED